BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 15895384)

  • 1. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
    Franke B; Galloway TS; Wilkin TJ
    Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
    Ongagna JC; Levy-Marchal C
    Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
    Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P
    Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
    Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
    Tsirogianni A; Pipi E; Soufleros K
    Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
    Prázný M; Skrha J; Límanová Z; Hilgertová J
    Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the idiotypes of insulin antibodies as markers for remission in Type 1 diabetes.
    Devendra D; Galloway TS; Horton SJ; Wilkin TJ
    Diabet Med; 2004 Dec; 21(12):1316-24. PubMed ID: 15569135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic autoimmunity of type I diabetes.
    Simone E; Eisenbarth GS
    Horm Metab Res; 1996 Jul; 28(7):332-6. PubMed ID: 8858379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
    Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
    Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [GAD antibody in IDDM].
    Yokota I; Shima K
    Rinsho Byori; 1998 Apr; 46(4):331-7. PubMed ID: 9594623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern concepts for the prediction of type 1 diabetes.
    Seissler J; Hatziagelaki E; Scherbaum WA
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S304-16. PubMed ID: 11460579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
    Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
    Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
    Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
    Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic autoantibodies in Tunisian children with newly diagnosed type 1 diabetes.
    Fakhfakh R; Haddouk S; Hadj Hamida YB; Kamoun T; Ayed MB; Hachicha M; Masmoudi H
    Pathol Biol (Paris); 2008 May; 56(3):130-2. PubMed ID: 18178035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
    Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
    Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.